Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phillips, Scott & Turner was a prominent pharmaceutical and consumer healthcare company, primarily known for its manufacturing and distribution of iconic over-the-counter brands such as Andrews Liver Salts and Phillips' Milk of Magnesia. Originally based in the United Kingdom and with significant operations in Australia, the company was acquired by Sterling Drug Inc. (which later became Sterling-Winthrop). Following the eventual breakup of Sterling-Winthrop in the 1990s, its brands and assets were integrated into larger pharmaceutical entities, including SmithKline Beecham (now GSK) and Sanofi. The company is historically significant for its role in the global expansion of magnesium-based digestive health products and effervescent salts. Today, its legacy brands continue to be marketed globally by Haleon and other successors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phillips Scott Turner.